Stay updated on Crizotinib in ROS1/MET Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page.

Latest updates to the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page history now lists a new release entry: Revision: v3.3.2, replacing Revision: v3.3.1 in the study's version history. This is an administrative update to release notes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision history shows a new entry for v3.3.1 added and v3.2.0 removed, reflecting a minor UI/versioning update rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the site-wide government funding operating status notice from the Record History page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check43 days agoChange DetectedThe screenshots show only minor UI/layout changes to the Record History page without any edits to study data or version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference13%

- Check79 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This signals a software/version update; no other content changes are evident from the provided additions/deletions.SummaryDifference0.3%

Stay in the know with updates to Crizotinib in ROS1/MET Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page.